These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27262025)

  • 1. Generation of HLA-Universal iPSC-Derived Megakaryocytes and Platelets for Survival Under Refractoriness Conditions.
    Börger AK; Eicke D; Wolf C; Gras C; Aufderbeck S; Schulze K; Engels L; Eiz-Vesper B; Schambach A; Guzman CA; Lachmann N; Moritz T; Martin U; Blasczyk R; Figueiredo C
    Mol Med; 2016 Sep; 22():274-285. PubMed ID: 27262025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.
    Figueiredo C; Blaszczyk R
    J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model.
    Gras C; Schulze K; Goudeva L; Guzman CA; Blasczyk R; Figueiredo C
    Hum Gene Ther; 2013 Dec; 24(12):1018-28. PubMed ID: 24090417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering.
    Figueiredo C; Blasczyk R
    Front Immunol; 2021; 12():768458. PubMed ID: 34777386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors.
    Eicke D; Baigger A; Schulze K; Latham SL; Halloin C; Zweigerdt R; Guzman CA; Blasczyk R; Figueiredo C
    Sci Rep; 2018 Jul; 8(1):10146. PubMed ID: 29977045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-scale generation of megakaryocytes from human embryonic stem cells using transgene-free and stepwise defined suspension culture conditions.
    Zhang B; Wu X; Zi G; He L; Wang S; Chen L; Fan Z; Nan X; Xi J; Yue W; Wang L; Wang L; Hao J; Pei X; Li Y
    Cell Prolif; 2021 Apr; 54(4):e13002. PubMed ID: 33615584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells.
    Norbnop P; Ingrungruanglert P; Israsena N; Suphapeetiporn K; Shotelersuk V
    Sci Rep; 2020 May; 10(1):8472. PubMed ID: 32439978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of HLA-deficient platelets from hematopoietic progenitor cells.
    Figueiredo C; Goudeva L; Horn PA; Eiz-Vesper B; Blasczyk R; Seltsam A
    Transfusion; 2010 Aug; 50(8):1690-701. PubMed ID: 20412529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward in Vitro Production of Platelet from Induced Pluripotent Stem Cells.
    Izady E; Saltanatpour Z; Liu LP; Alizadeh A; Hamidieh AA
    Stem Cell Rev Rep; 2022 Oct; 18(7):2376-2387. PubMed ID: 35397051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
    Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
    Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies.
    Meinke S; Sandgren P; Mörtberg A; Karlström C; Kadri N; Wikman A; Höglund P
    Transfusion; 2016 Feb; 56(2):370-82; quiz 369. PubMed ID: 26442787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients.
    Mirlashari MR; Vetlesen A; Nissen-Meyer LSH; Naper C; Tjønnfjord GE; Njerve IU; Ezligini F; Landmark BF; Meinke S; Sandgren P; Höglund P; Hetland G
    Transfusion; 2021 Apr; 61(4):1222-1234. PubMed ID: 33580979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of tumstatin in genetically modified megakaryocytes changes the proangiogenic effect of platelets.
    Li J; Luo J; Luo YQ; Zhou M; Zhao L; Yao LJ; Dong H; Yang RN
    Transfusion; 2014 Aug; 54(8):2106-17. PubMed ID: 24655355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies.
    Zhang N; Santoso S; Aster RH; Curtis BR; Newman PJ
    Blood; 2019 Nov; 134(22):e1-e8. PubMed ID: 31697836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-induced alloimmunization and platelet refractoriness in a mouse model: mechanisms and interventions.
    Waterman HR; Kapp LM; Munday A; Odem-Davis K; Zimring JC
    Transfusion; 2016 Jan; 56(1):91-100. PubMed ID: 26400622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mimicking megakaryopoiesis in vitro using biomaterials: Recent advances and future opportunities.
    Ingavle G; Shabrani N; Vaidya A; Kale V
    Acta Biomater; 2019 Sep; 96():99-110. PubMed ID: 31319203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of platelet transfusion refractoriness due to anti-CD36 with a successful treatment outcome.
    Khatri SS; Curtis BR; Yamada C
    Immunohematology; 2019 Dec; 35(4):139-144. PubMed ID: 31935329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical applications of iPS cell-derived platelets].
    Sugimoto N; Eto K
    Rinsho Ketsueki; 2022; 63(10):1430-1439. PubMed ID: 36351652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of in-vitro-derived megakaryocytes and platelets using spinning-membrane filtration.
    Schlinker AC; Radwanski K; Wegener C; Min K; Miller WM
    Biotechnol Bioeng; 2015 Apr; 112(4):788-800. PubMed ID: 25312394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalable generation of universal platelets from human induced pluripotent stem cells.
    Feng Q; Shabrani N; Thon JN; Huo H; Thiel A; Machlus KR; Kim K; Brooks J; Li F; Luo C; Kimbrel EA; Wang J; Kim KS; Italiano J; Cho J; Lu SJ; Lanza R
    Stem Cell Reports; 2014 Nov; 3(5):817-31. PubMed ID: 25418726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.